90 related articles for article (PubMed ID: 10723769)
21. New controlled-release ibuprofen tablets.
Palmieri GF; Lovato D; Martelli S
Drug Dev Ind Pharm; 1999 May; 25(5):671-7. PubMed ID: 10219538
[TBL] [Abstract][Full Text] [Related]
22. A burst drug release caused by imperfection of polymeric film-coated microparticles prepared by a fluidized bed coater.
Sriamornsak P; Casallas-Hernández GL; Manchun S; Kumpugdee-Vollrath M
Pharmazie; 2011 Aug; 66(8):576-83. PubMed ID: 21901979
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
24. Influence of rapeseed phospholipids on ibuprofen dissolution from solid dispersions.
Sosada M; Gorecki M; Pasker B
Pharmazie; 2006 Aug; 61(8):677-80. PubMed ID: 16964709
[TBL] [Abstract][Full Text] [Related]
25. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
[TBL] [Abstract][Full Text] [Related]
27. Ibuprofen-loaded ethylcellulose/polystyrene microspheres: an approach to get prolonged drug release with reduced burst effect and low ethylcellulose content.
Saravanan M; Bhaskar K; Srinivasa Rao G; Dhanaraju MD
J Microencapsul; 2003; 20(3):289-302. PubMed ID: 12881111
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
[TBL] [Abstract][Full Text] [Related]
29. Effect of manufacturing method on the in vitro drug release and adhesive performance of drug-in-adhesive films containing binary mixtures of ibuprofen with poloxamer 188.
Dodou K; Saddique W
Pharm Dev Technol; 2012; 17(5):552-61. PubMed ID: 21294623
[TBL] [Abstract][Full Text] [Related]
30. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
31. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Lamprecht A; Saumet JL; Roux J; Benoit JP
Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
[TBL] [Abstract][Full Text] [Related]
32. An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies.
García-Arieta A; Abad-Santos F; Rodríguez-Martínez MA; Varas-Polo Y; Novalbos J; Laparidis N; Gallego-Sandín S; Orfanidis K; Torrado J
Chirality; 2005 Oct; 17(8):470-5. PubMed ID: 16104026
[TBL] [Abstract][Full Text] [Related]
33. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
[TBL] [Abstract][Full Text] [Related]
36. In-vitro evaluation of sustained release ibuprofen microspheres.
Ghaly ES; Sepúlveda S
P R Health Sci J; 1996 Jun; 15(2):97-100. PubMed ID: 8936613
[TBL] [Abstract][Full Text] [Related]
37. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
Salunkhe KS; Kulkarni MV
Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
[TBL] [Abstract][Full Text] [Related]
38. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
[TBL] [Abstract][Full Text] [Related]
39. Initial salt screening procedures for manufacturing ibuprofen.
Lee T; Wang YW
Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
[TBL] [Abstract][Full Text] [Related]
40. Parmacokinetic evaluation of ibuprofen controlled release matrix tablets using hydrophilic Eudragit® polymer and co-excipients.
Bakhsh S; Khan GM; Menaa F; Khan BA
Pak J Pharm Sci; 2015 Sep; 28(5):1745-55. PubMed ID: 26408874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
